Case Study: Memorial Sloan Kettering expands outpatient immunotherapy delivery with Current Health

Memorial Sloan Kettering keeps 89% of bispecific patients outpatient with Current Health

Memorial Sloan Kettering faced the challenge of delivering advanced immunotherapies like CAR-T and bispecifics to a growing number of patients without sufficient inpatient bed capacity, while also reducing the significant burden of travel to their main Manhattan campus for many. To safely expand access and shift care closer to patients' homes, they partnered with Current Health and implemented its remote patient monitoring platform, which includes a wearable device and a 24/7 clinical command center.

The solution from Current Health provided continuous monitoring at home, enabling early detection of adverse events like fever and clear, protocol-driven escalation to ensure patient safety. This allowed Memorial Sloan Kettering to run a decentralized, hub-and-spoke model across its regional centers. In an 18-patient pilot for bispecific therapy, approximately 89% of patients completed their treatment entirely in the outpatient setting, avoiding week-long hospitalizations. The Current Health platform also provided several hours of early warning before clinical fever, enabling timely interventions and a safer, more manageable experience for patients and clinicians.

Memorial Sloan Kettering